设为首页 加入收藏

TOP

STIVARGA (regorafenib) tablet, film coated(十六)
2014-07-27 18:31:42 来源: 作者: 【 】 浏览:6178次 评论:0
sible side effects of Stivarga. For more information, ask your healthcare provider or pharmacist.
 
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How do I store Stivarga?
• Store Stivarga tablets at room temperature between 68° F to 77° F (20° C to 25° C). • Keep Stivarga in the bottle that it comes in. Do not put Stivarga tablets in a daily or weekly pill box. • The Stivarga bottle contains a desiccant to help keep your medicine dry. Keep the desiccant in the bottle. • Keep the bottle of Stivarga tightly closed. • Safely throw away (discard) any unused Stivarga tablets after 28 days of opening the bottle.
Keep Stivarga and all medicines out of the reach of children.

General information about Stivarga.

Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use Stivarga for a condition for which it was not prescribed. Do not give Stivarga to other people even if they have the same symptoms you have. It may harm them.
 
This leaflet summarizes the most important information about Stivarga. If you would like more information, talk with your healthcare provider. You can ask your healthcare provider or pharmacist for information about Stivarga this is written for healthcare professionals.

For more information, go to www.STIVARGA-US.com or call 1-888-842-2937.
 
What are the ingredients in Stivarga?

Active ingredient: regorafenib
 
Inactive ingredients: cellulose microcrystalline, croscarmellose sodium, magnesium stearate, povidone and colloidal silicon dioxide.
 
Film coat: ferric oxide red, ferric oxide yellow, lecithin (soy), polyethylene glycol 3350, polyvinyl alcohol, talc and titanium dioxide.
 
This Patient Information has been approved by the U.S. Food and Drug Administration.
 
Manufactured in Germany
 
Distributed and marketed by:

Bayer HealthCare Pharmaceuticals Inc.,
 
Wayne, NJ 07470
 
© 2012 Bayer HealthCare Pharmaceuticals Inc.
 
Issued: 09/2012

STIVARGA
regorafenib tablet, film coated

Product Information

Product Type

HUMAN PRESCRIPTION DRUG

Item Code (Source)

NDC:50419-171

Route of Administration

ORAL

DEA Schedule


Active Ingredient/Active Moiety

Ingredient Name

Basis of Strength

Strength

REGORAFENIB (REGORAFENIB)

REGORAFENIB

40 mg
 
Inactive Ingredients

Ingredient Name

Strength

CELLULOSE, MICROCRYSTALLINE

CROSCARMELLOSE SODIUM

MAGNESIUM STEARATE


SILICON DIOXIDE

FERRIC OXIDE RED

FERRIC OXIDE YELLOW

LECITHIN, SOYBEAN


POLYETHYLENE GLYCOL 3350

POLYVINYL ALCOHOL


TALC

TITANIUM DIOXIDE

POVIDONE

Product Characteristics
 
Color

PINK (light)

Score

 no score

 

Shape

OVAL

Size

16mm
 
Flavor


Imprint Code

 BAYER

Contains

Packaging

#

Item Code

Package Description

Multilevel Packaging

1

NDC:50419-171-03

3 BOTTLE, PLASTIC in 1 BOX

contains a BOTTLE, PLASTIC (50419-171-01)
 
1

NDC:50419-171-01

28 TABLET, FILM COATED in 1 BOTT

以下是“全球医药”详细资料
Tags: 责任编辑:admin
首页 上一页 13 14 15 16 17 下一页 尾页 16/17/17
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇YAZ(drospirenone and ethinyl es.. 下一篇Viread

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位